Centre issues key guidelines for the management of COVID-19 among children

DGHS has recommended against using Remdesivir fortreatment of COVID-19 among children

The Centre on Wednesday issued a list of comprehensive guidelines for managing COVID-19 among children below the age of 18 years. This development has come amid fears of a third COVID-19 wave in India that is largely expected to impact children. Under the Union Health Ministry, the Directorate General of Health Services (DGHS) released the guidelines to ensure appropriate care of children from COVID-19.

In the guidelines, the DGHS has recommended against using emergency drug Remdesivir for the treatment of children due to lack ofrelevant efficacy and safety data for those aged below 18.

At the same time, the authorities have advised against using steroids and self-medication in asymptomatic and mild cases of infection. “Steroids should be used at the right time, in right dose and for the right duration in critically ill COVID-19 cases under strict supervision,” the guidelines added.

The guidelines also state that antimicrobials are not recommended for therapy or prophylaxis among asymptomatic and mild cases. For moderate and severe cases, antimicrobials should not be prescribed unless there is clinical suspicion of a superadded infection. The government has approved the rational use of High-resolution CT (HRCT) imaging carried out by highly selective physicians. HRCT scan helps in better visualising the extent and nature of lung involvement inCOVID-19 patients.

Related Posts

Parents can give paracetamol 10-15mg/dose every 4-6 hours and aspirin 3-5mg/day to children in case of mild infection to control fever and soothe the throat. Meanwhile, warm saline gargles can be used forolder children and adolescents to cure cough

“Ensure oral fluids to maintain hydration and give a nutritious diet. No other COVID-19 specific medication needed,” the guidelines said.

Furthermore, children below the age of 5 are not required to wear a mask as per the DHGS guidelines.

It is important to regularly monitor the health status of children, including counting their respiratory rate 2-3 times a day, checking for bluish discolouration of body, cold extremities, oxygen saturation, and other activity levels among young children.

Meanwhile, amid the ongoing national vaccination efforts, Bharat Biotech has begun the trial for Covaxin among children aged between 2 and 18 at AIIMS Delhi and Patna. According to reports, if phase 2/3 trials show positive results among children, Covaxin would be used in vaccinating the age group of 2-18 years against COVID-19 in India.

CV Journalist

Dr. Neha Mathur, a distinguished member of the India Observers team, specializes in Health and Wellness. With a profound commitment to keeping our readers informed, Dr. Neha shares expert insights on health-related topics. Navigate the world of well-being with Dr. Neha's expertise and dedication to your health journey.

Recent Posts

Jaishankar Rules Out Bilateral Talks with Pakistan at SCO Summit

External Affairs Minister of India, S Jaishankar is set to visit Pakistan in mid-October to…

October 5, 2024

Dubai Hosts Thrilling South Africa-West Indies Clash in T20 World Cup

ICC Women’s T20 World Cup 2024 kicked off in Dubai with an exciting face-off between…

October 4, 2024

Kick 2 Is Happening! Sajid Nadiadwala Drops First Look of Salman Khan’s Iconic Return

Salman Khan fans have something big to celebrate! Producer Sajid Nadiadwala has officially announced the…

October 4, 2024

Power Outage in Chennai on October 4: Is Your Area on the List?

Chennai will have a power cut on October 4, 2024, as reported by various news…

October 4, 2024

Google Enhances Search Engine with AI-Powered Video and Image Search

As part of the next phase in developing the company’s artificial intelligence, Google is to…

October 4, 2024

OpenAI Secures $6.6 Billion in Funding to Boost AI Research

According to the news sources like Reuters, OpenAI has successfully raised $6.6 billion in new…

October 3, 2024

This website uses cookies.

Read More